13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 2 managers

Reported value

$3.64M

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$1.35M

Price effect on 2 books still in the name

Largest holder

$3.45M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC758K$3.45M−$1.32MCut−$279.7K
Leonteq Securities AG41.4K$188.4K−$26.9KAdded$112.4K

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.